Kevin Norrett - Chief Business Officer at SOLENO THERAPEUTICS INC

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Business Officer
Issuer Symbol
SLNO on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Kevin Norrett since 11 Mar 2025

Holdings reported by Kevin Norrett for SOLENO THERAPEUTICS INC

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 17,786 $823,477 $46.30 21 Jan 2026 Direct
Employee stock option (right to buy) 4,000 21 Jan 2026 Direct Common Stock

Transactions reported by Kevin Norrett for SOLENO THERAPEUTICS INC

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.